11 min listen
ACCEL Lite: Are Primary Prevention ICDs Still Valuable in NICM?
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: Are Primary Prevention ICDs Still Valuable in NICM?
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
19 minutes
Released:
Apr 27, 2021
Format:
Podcast episode
Description
Current guidelines recommend implantable cardioverter-defibrillators (ICDs) in nonischemic cardiomyopathy (NICM) among patients with heart failure and ejection fraction ≤35%. Should this change? Should cardiac resynchronization therapy pacemakers be considered in patients with NICM and left bundle branch block? What were the data to support the use of ICDs for primary prevention in NICM? In this episode, Rachel Lampert, MD, moderates a debate between Michael R. Gold, MD, PhD, and Eric N. Prystowsky, MD, FACC, about whether primary prevention ICDs are still a valuable therapy in patients with NICM. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.
Released:
Apr 27, 2021
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: Universal Definition of HF Syndrome: Evolving Strategies: The new universal heart failure (HF) definition will be easier for patients and clinicians to understand and will provide standardization across different societies. In this interview, Allen Taylor, MD, FACC; Biykem Bozkurt, MD, PhD, FACC; and... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research